DE69523356T2 - Verfahren zur Herstellung von Liposomen enthaltenden kosmetischen oder pharmazeutischen Zusammensetzungen - Google Patents

Verfahren zur Herstellung von Liposomen enthaltenden kosmetischen oder pharmazeutischen Zusammensetzungen

Info

Publication number
DE69523356T2
DE69523356T2 DE69523356T DE69523356T DE69523356T2 DE 69523356 T2 DE69523356 T2 DE 69523356T2 DE 69523356 T DE69523356 T DE 69523356T DE 69523356 T DE69523356 T DE 69523356T DE 69523356 T2 DE69523356 T2 DE 69523356T2
Authority
DE
Germany
Prior art keywords
aryl
halogen
cosmetic
opt
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69523356T
Other languages
English (en)
Other versions
DE69523356D1 (de
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69523356D1 publication Critical patent/DE69523356D1/de
Publication of DE69523356T2 publication Critical patent/DE69523356T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69523356T 1994-02-16 1995-02-15 Verfahren zur Herstellung von Liposomen enthaltenden kosmetischen oder pharmazeutischen Zusammensetzungen Expired - Fee Related DE69523356T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401755A FR2716110B1 (fr) 1994-02-16 1994-02-16 Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.

Publications (2)

Publication Number Publication Date
DE69523356D1 DE69523356D1 (de) 2001-11-29
DE69523356T2 true DE69523356T2 (de) 2002-07-11

Family

ID=9460135

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523356T Expired - Fee Related DE69523356T2 (de) 1994-02-16 1995-02-15 Verfahren zur Herstellung von Liposomen enthaltenden kosmetischen oder pharmazeutischen Zusammensetzungen

Country Status (16)

Country Link
US (1) US6162444A (de)
EP (1) EP0671156B1 (de)
JP (1) JPH07309754A (de)
KR (1) KR100407902B1 (de)
CN (1) CN1149971C (de)
AT (1) ATE207337T1 (de)
AU (1) AU701344B2 (de)
CA (1) CA2141506A1 (de)
DE (1) DE69523356T2 (de)
DK (1) DK0671156T3 (de)
ES (1) ES2163478T3 (de)
FR (1) FR2716110B1 (de)
HU (1) HU218578B (de)
PT (1) PT671156E (de)
RU (1) RU2131731C1 (de)
ZA (1) ZA951281B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6132582A (en) 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
IL142598A0 (en) * 1998-10-23 2002-03-10 Aventis Pharma Gmbh Preparations for topical application of substances having antiandrogenic effect
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
CA2413417A1 (en) 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (de) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
PL206962B1 (pl) 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej
US6875438B2 (en) * 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
DE50211883D1 (de) * 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US7074418B2 (en) * 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
US7407623B2 (en) * 2003-12-09 2008-08-05 Ge Betz, Inc. Steam condensate corrosion inhibitor compositions and methods
WO2006042701A1 (de) * 2004-10-18 2006-04-27 Polymun Scientific Immunbiologische Forschung Gmbh Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
US9006487B2 (en) * 2005-06-15 2015-04-14 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
TW201111378A (en) 2009-09-11 2011-04-01 Bayer Schering Pharma Ag Substituted (heteroarylmethyl) thiohydantoins
RU2503446C2 (ru) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Средство для роста волос (варианты) и способ лечения облысения
CN103965112A (zh) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 一种具有抗雄激素活性的化合物、制备方法及其应用
EP3886853A4 (de) 2018-11-30 2022-07-06 Nuvation Bio Inc. Diarylhydantoiverbindungen und verfahren zur verwendung davon
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (fr) 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2627385B3 (fr) * 1988-02-23 1991-08-23 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
FR2631234B1 (fr) 1988-05-10 1990-09-14 Dior Christian Parfums Composition cosmetique ou dermatologique, notamment a action amincissante ou anti-cellulitique contenant des extraits de cola sous forme libre ou sous forme liposomale
US5204105A (en) * 1990-04-10 1993-04-20 Chanel, Inc. Cosmetic composition
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut

Also Published As

Publication number Publication date
CN1149971C (zh) 2004-05-19
RU95101833A (ru) 1997-02-27
FR2716110A1 (fr) 1995-08-18
AU701344B2 (en) 1999-01-28
HU218578B (hu) 2000-10-28
DK0671156T3 (da) 2002-02-04
AU1227795A (en) 1995-08-24
RU2131731C1 (ru) 1999-06-20
ES2163478T3 (es) 2002-02-01
CA2141506A1 (fr) 1995-08-17
HU9500454D0 (en) 1995-04-28
PT671156E (pt) 2002-03-28
EP0671156B1 (de) 2001-10-24
CN1112416A (zh) 1995-11-29
KR100407902B1 (ko) 2004-03-09
EP0671156A1 (de) 1995-09-13
DE69523356D1 (de) 2001-11-29
JPH07309754A (ja) 1995-11-28
FR2716110B1 (fr) 1996-04-05
US6162444A (en) 2000-12-19
ZA951281B (en) 1996-02-16
ATE207337T1 (de) 2001-11-15
HUT72021A (en) 1996-03-28
KR950031033A (ko) 1995-12-18

Similar Documents

Publication Publication Date Title
DE69523356D1 (de) Verfahren zur Herstellung von Liposomen enthaltenden kosmetischen oder pharmazeutischen Zusammensetzungen
DE69113604D1 (de) Quinoloncarbonsäurederivat.
DE69324859T2 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
FI93450B (fi) Menetelmä terapeuttisesti käyttökelpoisten 10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/undek-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
FR2651122B1 (fr) Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
DE69735090D1 (de) Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen
HUP0100470A2 (hu) Oxazolidinonszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
DE69500511T2 (de) Phosphatdiester zur Behandlung von proliferativen Erkrankungen der Epidermis
HUT66410A (en) Benzomorphan derivatives and pharmaceutical compositions containing them
ATE151288T1 (de) N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
DE69006452D1 (de) Derivate und Analoge von Pyrimidon zur Behandlung von Asthma und bestimmte Hautkrankheiten.
ATE201022T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
GEP19981225B (en) Herbicidal Picolinamide Derivatives
DE69217717D1 (de) Benzopyranderivate und Verfahren zu deren Herstellung
ATE18763T1 (de) Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel.
DE69509268D1 (de) Lungentransplantat-Konservierungsmittelmischung und Verfahren zur Lebendkonservierung von Lungentransplantaten
DE69820911D1 (de) Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren
DE69810332D1 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung
HUP0400916A2 (hu) Transzdermális terápiás készítmény a gyapjú- és hajhullás megelőzésére és/vagy kezelésére
NZ509327A (en) Alpha-amino acid phenyl ester derivatives for use in general anaesthesia
DE602004002792D1 (de) Paraphenylendiamin Derivate auf Basis einer zyklischen Diaza-Verbindung substituiert mit einem kationischen Radikal und Verwendung dieser Derivate zur Färbung von Keratinfasern
ATE183637T1 (de) Mittel zur dauerhaften verformung von menschlichen haaren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8339 Ceased/non-payment of the annual fee